Compounds > phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide

phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide and 1-(5-isoquinolinesulfonyl)-2-methylpiperazine

phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide has been researched along with 1-(5-isoquinolinesulfonyl)-2-methylpiperazine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernstein, RN; Bilsky, EJ; Porreca, F; Sadée, W; Wang, Z1

Other Studies

1 other study(ies) available for phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide and 1-(5-isoquinolinesulfonyl)-2-methylpiperazine

ArticleYear
Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 277, Issue:1

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amino Acid Sequence; Analgesics, Opioid; Animals; Drug Tolerance; Enzyme Inhibitors; Isoquinolines; Male; Mice; Mice, Inbred ICR; Molecular Sequence Data; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Peptide Fragments; Peptides; Piperazines; Protein Kinase C; Receptors, Opioid, mu; Somatostatin

1996